A Study of the Efficacy and Safety of Supaglutide in Healthy Participants

NCT03745885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Supaglutide injection
DRUG: Placebo

Sponsor

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Collaborators

[object Object]